Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Serotonergic 5-HT1A and 5-HT2A receptors are abundantly expressed in prefrontal cortex (PFC) and are targets of atypical antipsychotic drugs. They mediate, respectively, inhibitory and excitatory actions of 5-HT. The transcripts for both receptors are largely (approximately 80%) colocalized in rat and mouse PFC, yet their quantitative distribution in pyramidal and GABAergic interneurons is unknown. We used double in situ hybridization histochemistry to estimate the proportion of pyramidal and GABAergic neurons expressing these receptor transcripts in rat PFC. The number of GABAergic interneurons (expressing GAD mRNA) was a 22% of glutamatergic neurons (expressing vGluT1 mRNA, considered as putative pyramidal neurons). 5-HT2A receptor mRNA was present in a large percentage of pyramidal neurons (from 55% in prelimbic cortex to 88% in tenia tecta), except in layer VI, where it was localized only in 30% of those neurons. 5-HT2A receptor mRNA was present in approximately 25% of GAD-containing cells except in layer VI (10%). Likewise, approximately 60% of glutamatergic cells contained the 5-HT1A receptor transcript. We also found that approximately 25% of GAD-expressing cells contained the 5-HT1A receptor mRNA. These data help to clarify the role of 5-HT in prefrontal circuits and shed new light to the cellular elements involved in the action of atypical antipsychotics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [208]
In the citing paper
“These receptors mediate, respectively, the inhibitory and excitatory actions of 5-HT on cortical neurons (108); thus these alterations may produce further functional abnormalities in the anterior cingulate cortex.”
From Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies (2009) · cites this paper as [108]
In the citing paper
“amplifies 5-HT1A-R-mediated inhibition of GABAergic interneurons (Santana et al., 2004) to disinhibit glutamatergic output in downstream structures (Llado-Pelfort et al., 2012).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Santana et al., 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“Cortical areas designated according to Paxinos and Watson (1998) and Swanson (1998).”
Azmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909 · cited 2×
“The prefrontal cortex receives a moderate to dense serotonergic innervation from the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palac…”
BackgroundBrain Maps: Structure of the Rat Brain
Swanson, L. W. (1992) · Medical Entomology and Zoology · Cited by 1,878
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 2×
“…the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palacios, 1985; Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundSesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568 · cited 2×
“Of particular interest are the many neurons of the prelimbic and infralimbic areas expressing 5-HT2A and/or 5-HT1A receptors, since these areas project to midbrain serotonergic and dopaminergic cells and influence their activity (Thierry et al., 1983; Sesack et al., 1989; Hajós et al., 1998; Peyron et al., 1998; Carr…”
BackgroundLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 1×
“This effect would attenuate the presumed hyperactivity of mesolimbic dopamine neurons in schizophrenic patients (Weinberger et al., 1994; Laruelle et al., 1996).”
BackgroundThe Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse
Fremeau, R. T., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J., & Edwards, R. H. (2001) · Neuron · doi:10.1016/s0896-6273(01)00344-0 · Cited by 1,265
Two genes encode distinct glutamate decarboxylases
Erlander, M. G., Tillakaratne, N. J. K., Feldblum, S., Patel, N., & Tobin, A. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90077-d · Cited by 1,213 · cited 1×
“Immunohistochemical and in situ hybridization histochemistry indicate that the majority of GABA-containing neurons in the brain co-express the genes encoding the two GAD isoforms (Erlander et al., 1991; Esclapez et al., 1993, 1994; Feldblum et al., 1993).”
BackgroundPompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881 · cited 3×
“The distribution of cells expressing the receptor transcripts agrees well with the regional patterns of distribution of the respective mRNA and protein, as assessed autoradiographically (Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundCarr, D. B., & Sesack, S. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03864.2000 · Cited by 880 · cited 3×
“The occupancy of these pyramidal receptors by atypical antipsychotics should conceivably result in a diminished excitatory input onto mesolimbic dopaminergic neurons, innervated by prefrontal afferents (Thierry et al., 1983; Carr and Sesack, 2000).”
Background
Cited by
Items 101–200 of 546
Pockros, L. A., Pentkowski, N. S., Swinford-Jackson, S. E., & Neisewander, J. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2071-9 · Cited by 88
“In the mPFC, 5HT2A receptors are located postsynaptically, primarily on apical dendrites of pyramidal neurons with a minority found on GABA interneurons (Cornea-Hebert et al. 1999; Hamada et al. 1998; Jakab and Goldman-Rakic 1998; Santana et al. 2004; Willins et al. 1997).”
Revisiting enigmatic cortical calretinin-expressing interneurons
Cauli, B., Zhou, X., Tricoire, L., Toussay, X., & Staiger, J. F. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00052 · Cited by 86
“Nevertheless, 5-HT1a and 5-HT2a receptors are largely coexpressed in pyramidal cells and in a minority of interneurons positive for PV+ or CB+ (Aznar et al., 2003; Santana et al., 2004), suggesting that CR+ bipolar interneurons barely express these receptors.”
BackgroundLopez-Gil, X., Artigas, F., & Adell, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361416 · Cited by 77
“Both 5-HT2A and 5-HT1A receptors show a ~80% colocalization in the mPFC [124] with a high level of expression in pyramidal cells labeled by vGluT1 [127].”
BackgroundResultInfluentialCarli, M., & Invernizzi, R. W. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00058 · Cited by 74
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex
Nocjar, C., Alex, K. D., Sonneborn, A., Abbas, A. I., Roth, B. L., & Pehek, E. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.050 · Cited by 85
“5-HT1ARs and 5-HT2ARs are co-localized on the majority of pyramidal neurons in the region (Martin-Ruiz et al., 2001;Amargos-Bosch et al., 2004;Santana et al., 2004;Puig et al., 2010) and evidence of their opposing cross-talk has been reported (Araneda and Andrade, 1991;Berg et al.,…”
BackgroundFerrés‐Coy, A., Santana, N., Castañé, A., Cortés, R., Carmona, M. C., Tóth, M., Montefeltro, A., Artigas, F., & Bortolozzi, A. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2795-9 · Cited by 85
“Probes labeling and in situ hybridization procedures were carried out as described previously (Bortolozzi et al. 2012; Santana et al. 2004).”
BackgroundMethodSelf-citationSakashita, Y., Abe, K., Katagiri, N., Kambe, T., Saitoh, T., Utsunomiya, I., Horiguchi, Y., & Taguchi, K. (2015) · Biological ^|^ Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00315 · Cited by 81
Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis
Brunet, A., Stuart‐Lopez, G., Burg, T., Scekic‐Zahirovic, J., & Rouaux, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00363 · Cited by 81
“In the rodent motor cortex, serotonergic projections are found in every cortical layers (Vertes et al., 1999) and mainly act on excitatory neurons (Santana, 2004).”
BackgroundGene Expression Switching of Receptor Subunits in Human Brain Development
Bar-Shira, O., Maor, R., & Chechik, G. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004559 · Cited by 74
“5-HT1 acts as an autoreceptor on serotonergic neurons [63,64], and mediates hyperpolarization of 5-HT on prefrontal neurons [65].”
BackgroundRiga, M. S., Soria, G., Tudela, R., Artigas, F., & Celada, P. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000261 · Cited by 72
“The opposite effects on neuronal discharge may result from the activation of 5-HT2A-R in the recorded pyramidal neurons or in adjacent GABAergic interneurons, respectively, given the expression of 5-HT2A-R in both neuronal types (Santana et al., 2004) and the involvement of GABAergic interneurons in the inhibitory act…”
BackgroundBhagwagar, Z., Murthy, N., Selvaraj, S., Hinz, R., Taylor, M., Fancy, S., Grasby, P., & Cowen, P. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111933 · Cited by 71
Prefrontal afferents to the dorsal raphe nucleus in the rat
Gonçalves, L., Nogueira, M. I., Shammah‐Lagnado, S. J., & Metzger, M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.11.012 · Cited by 78
Barlow, R. L., Alsiö, J., Jupp, B., Rabinovich, R., Shrestha, S., Roberts, A. C., Robbins, T. W., & Dalley, J. W. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.335 · Cited by 77
“The OFC receives a dense serotonergic innervation 73 from the dorsal raphé nucleus (DRN), which in turn provides regulatory input to the DRN 74 (Azmitia and Segal, 1978; Peyron et al, 1998; Santana et al, 2004).”
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
Venzi, M., David, F., Bellet, J., Cavaccini, A., Bombardi, C., Crunelli, V., & Giovanni, G. D. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.016 · Cited by 77
“5-HT2ARs and 5-HT2CRs are present in cortical GABAergic interneurons, and to a lesser extent in pyramidal neurons both in rats (Nocjar et al., 2015; Santana et al., 2004) and in primates (De Almeida and Mengod, 2007).”
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy
Bowen, D. M., PROCTER, A. W., Mann, D. M. A., Snowden, J. S., Esiri, M. M., Neary, D., & Francis, P. T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0992-8 · Cited by 77
“…immunohistochemistry, in situ hybridisation histochemistry and positron emission tomography (PET) support the view that in the cerebral cortex, 5-HT1A receptors index the soma of pyramidal neurones (Francis et al. 1992, 1993a; Kepe et al. 2006; Kia et al. 1996; Santana et al. 2004).”
BackgroundHiggins, G. A., Carroll, N. K., Brown, M., MacMillan, C., Silenieks, L. B., Thevarkunnel, S., Izhakova, J., Magomedova, L., DeLannoy, I., & Sellers, E. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640241 · Cited by 69
“5-HT2A receptors are widely distributed within cortical zones, notably layer II-V (Santana et al., 2004; Mengod et al., 2015), and also in subcortical regions such as the DA nigrostriatal and mesocorticolimbic pathways where they appear to positively regulate tone, at least under certain physiological conditions (Dohe…”
BackgroundIderberg, H., McCreary, A. C., Varney, M. A., Cenci, M. A., & Newman‐Tancredi, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.012 · Cited by 76
Delille, H. K., Mezler, M., & Marek, G. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.005 · Cited by 75
“In contrast to mGlu2, the vast majority of 5-HT2A receptors is localized postsynaptically on pyramidal neurons with a second minor subpopulation on GABAergic interneurons (de Almeida and Mengod, 2007; Jakab and Goldman-Rakic, 1998; Miner et al., 2003; Santana et al., 2004; Weber and Andrade, 2010).”
BackgroundPsychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 74
“…and electron microscope immunocytochemistry (Cornea- Hébert et al., 1999), in situ hybridization (AmargósBosch et al., 2004; Burnet et al., 1995; Santana et al., 2004), receptor autoradiography (Pazos et al., 1987; Quirion et al., 1985), and transgenic mice expressing GFP under control of the…”
BackgroundDEALMEIDA, J., Palacios, J. M., & Mengod, G. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00905-9 · Cited by 73
Bétry, C., Pehrson, A. L., Etiévant, A., Ebert, B., Sánchez, C., & Haddjeri, N. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001058 · Cited by 62
“Differently, 5-HT2A receptors are essentially localized on pyramidal neurons, thus their stimulation induced an excitatory effect (Jakab & Goldman-Rakic, 1998; Santana et al. 2004).”
BackgroundMeloni, E. G., Reedy, C. L., Cohen, B. M., & Carlezon, W. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.016 · Cited by 71
“Possible mechanisms for the inhibitory effects of 5-HT on mPFC pyramidal neurons include direct effects, mediated by 5HT1A receptors, or indirect effects, mediated through activation of GABAergic interneurons via 5-HT2A and/or 5HT-3 receptors [57-59].”
Smausz, R., Neill, J. C., & Gigg, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092508 · Cited by 70
“…the 5HT2A-R and 5HT1A-R in humans (Carhart-Harris and Nutt, 2017) and rodents (Amargós-Bosch et al., 2004), while a quarter of the INs also express these (Carhart-Harris and Nutt, 2017; Santana et al., 2004), it is difficult to predict psilocin’s overall effect on activity within this region.”
BackgroundMocci, G., Jiménez-Sánchez, L., Adell, A., Cortés, R., & Artigas, F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.021 · Cited by 70
“presence in a large proportion of PFC pyramidal and GABAergic neurons in rodent and human brains (Amargós-Bosch et al., 2004; de Almeida and Mengod, 2007, 2008; Santana et al., 2004).”
InfluentialLópez-Gil, X., Artigas, F., & Adell, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009267 · Cited by 70
“In addition, the high level of expression of 5-HT2A and 5-HT1A receptors in pyramidal cells labelled by vGluT1 (Santana et al., 2004) together with the high co-localization of both receptors in the mPFC (y80%; Amargós-Bosch et al.”
BackgroundResultLi, L., Zhang, L., He, Z., Ma, H., Zhang, Y., Xun, Y., Yuan, W., Hou, W., Li, Y.-T., Lv, Z., et al. (2021) · eLife · doi:10.7554/elife.67638 · Cited by 69
Evans, K. C., Simon, N. M., Dougherty, D. D., Hoge, E. A., Worthington, J. J., Chow, C., Kaufman, R. E., Gold, A. L., Fischman, A. J., Pollack, M. H., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.69 · Cited by 68
“Moreover, emerging evidence indicates significant interaction between serotonergic and GABAergic systems within the PFC (Santana et al, 2004; Lanzenberger et al, 2007).”
Conn, K., Milton, L. K., Huang, K., Munguba, H., Ruuska, J., Lemus, M. B., Greaves, E., Homman‐Ludiye, J., Oldfield, B. J., & Foldi, C. J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02575-9 · Cited by 68
Ramirez-Mahaluf, J. P., Roxin, A., Mayberg, H. S., & Compte, A. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv249 · Cited by 58
“…uneven distribution of serotonin receptors in the cingulate gyrus, with the highest density of 5-hydroxytryptamine (5-HT 1A ) receptors in the vACC (Santana et al. 2004; Palomero-Gallagher et al. 2009), suggests that the selective action of SSRI treatments might bemediated…”
BackgroundMethodErritzoe, D., Holst, K., Frokjaer, V. G., Licht, C. L., Kalbitzer, J., Nielsen, F. Å., Svarer, C., Madsen, J., & Knudsen, G. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2852-09.2010 · Cited by 59
“The cerebral 5-HT2A receptors are mainly expressed on glutamatergic pyramidal neurons, cholinergic neurons, and GABAergic interneurons (Morilak et al., 1994; Santana et al., 2004), and, in most areas of the forebrain, regional variations in their density correspond closely to the 5-HT axon innervation (Blue et al.”
BackgroundSerotonin2A receptor binding potential in people with aggressive and violent behaviour
Meyer, J. H., Wilson, A. A., Rusjan, P., Clark, M., Houle, S., Woodside, S., Arrowood, J., Martin, K., & Colleton, M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0847 · Cited by 55
Wierońska, J. M., Stachowicz, K., Pałucha-Poniewiera, A., Acher, F., Brański, P., & Pilc, A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.008 · Cited by 66
León, L. A., Gomes, V. D. C., Zárate-Guerrero, S., Corredor, K., Cruz, A. P. D. M., Brandão, M. L., Cárdenas, F. P., & Landeira-Fernández, J. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00117 · Cited by 65
“Moreover, 5-HT2 receptors, but mainly the 5-HT2A receptor subtype, are widely and densely distributed in both the PL and IL (Pazos et al., 1985; Pompeiano et al., 1994; Santana et al., 2004).”
BackgroundAznar, S., & Klein, A. B. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8472-0 · Cited by 64
“HT2A receptor mRNA is present in 25 % of GABAergic interneurons except in layer VI (10 %) [45].”
Tanahashi, S., Yamamura, S., Nakagawa, M., Motomura, E., & Okada, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.031 · Cited by 63
“Furthermore, the 5-HT1A receptor is expressed in both pyramidal neurons and GABAergic interneurons in frontal cortex (Aznar et al., 2003; Santana et al., 2004), and activation of 5-HT1A receptor in vivo suppressed pyramidal neurons (AmargosBosch et al.”
BackgroundFlanagan, T. W., Sebastian, M. N., Battaglia, D. M., Foster, T. P., Cormier, S. A., & Nichols, C. D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116790 · Cited by 57
Distribution of 5-HT Receptors in the Central Nervous System
Mengod, G., Cortés, R., Vilaró, M. T., & Hoyer, D. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70074-6 · Cited by 63
Zhong, P., & Yan, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016970 · Cited by 53
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. D. A., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., Costa, K. C. M., Campos, A. C., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06196-4 · Cited by 62
“Conversely, CBD facilitates 5‐HT1A‐ mediated neurotransmission in the prefrontal cortex, modu‐ lating glutamate and GABA function (Santana et al. 2004; Russo et al. 2005).”
BackgroundSerotonin Regulates Performance Nonmonotonically in a Spatial Working Memory Network
Cano-Colino, M., Almeida, R., Gomez-Cabrero, D., Artigas, F., & Compte, A. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht096 · Cited by 58
The prefrontal cortex: a target for antipsychotic drugs
Artigas, F. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01455.x · Cited by 61
Santana, N., Mengod, G., & Artigas, F. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001083 · Cited by 45
“It adds to similar studies on 5-HT and dopamine receptors relevant for antipsychotic drug action (Amargó s-Bosch et al. 2004 ; Puig et al. 2004 ; Santana et al. 2004, 2009).”
InfluentialSelf-citationSerotonin 1B Receptors Regulate Prefrontal Function by Gating Callosal and Hippocampal Inputs
Kjaerby, C., Athilingam, J., Robinson, S. E., Iafrati, J., & Sohal, V. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.036 · Cited by 55
“In mPFC, as well as other forebrain regions, serotonin is generally believed to modulate circuit function through postsynaptic effects (Crino et al., 1990; de Almeida and Mengod, 2008; Santana et al., 2004).”
BackgroundSeparable gain control of ongoing and evoked activity in the visual cortex by serotonergic input
Azimi, Z., Barzan, R., Spoida, K., Surdin, T., Wollenweber, P., Mark, M. D., Herlitze, S., & Jancke, D. (2020) · eLife · doi:10.7554/elife.53552 · Cited by 61
Cartography of 5-HT1Aand 5-HT2AReceptor Subtypes in Prefrontal Cortex and Its Projections
Mengod, G., Palacios, J. M., & Cortés, R. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00023 · Cited by 59
Serotonin in antipsychotic drugs action
Amato, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.025 · Cited by 58
Warneke, W., Klaus, S., Fink, H., Langley‐Evans, S. C., & Voigt, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.016 · Cited by 58
Komlósi, G., Molnár, G., Rózsa, M., Oláh, S., Barzó, P., & Tamás, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2618-12.2012 · Cited by 57
“Pharmacology of 5-HT-induced suppression of mono- and polysynaptic events The prefrontal cortex is enriched in 5HT-1A, 5HT-2A and 5-HT 3 receptors in rodents, primates and humans (Jakab and Goldman-Rakic, 2000; DeFelipe et al., 2001; Celada et al., 2004; Santana et al., 2004; de Almeida and Mengod, 2007; Puig et al.,…”
BackgroundAnastasio, N. C., Stoffel, E. C., Fox, R. G., Bubar, M. J., Rice, K. C., Moeller, F. G., & Cunningham, K. A. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328345f90d · Cited by 55
“The 5-HT2AR expressed within the limbic corticostriatal circuit serves to modulate dopaminergic (Auclair et al., 2004; Broderick et al., 2004), noradrenergic (Millan et al., 2000), and/or glutamatergic neurotransmission (Santana et al., 2004; Carli et al., 2006).”
BackgroundPałucha-Poniewiera, A., Brański, P., Lenda, T., & Pilc, A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169730 · Cited by 55
“5-HT1A receptors are localized presynaptically on serotonergic neurons in the raphe, where they play the role of autoreceptors and postsynaptically mainly on nonserotonergic neurons, including glutamatergic ones (Santana et al., 2004).”
BackgroundCalcagno, E., Carli, M., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03600.x · Cited by 54
“The mPFC receives an extensive serotonin (5-HT) innervation from the raphe nuclei (Azmitia and Segal 1978) and is highly enriched in various 5-HT receptors, particularly the 5-HT1A subtype which is mainly localized on glutamatergic pyramidal neurons and, to a lesser extent, non-pyramidal neurons (Amargos-Bosch et al.…”
BackgroundSargin, D., Jeoung, H.-S., Goodfellow, N. M., & Lambe, E. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00073 · Cited by 54
ncx1,ncx2, andncx3Gene Product Expression and Function in Neuronal Anoxia and Brain Ischemia
Annunziato, L., Pignataro, G., Boscia, F., Sirabella, R., Formisano, L., Saggese, M., Cuomo, O., Gala, R., Secondo, A., Viggiano, D., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1387.050 · Cited by 54
Neuronal localization of 5-HT2A receptor immunoreactivity in the rat hippocampal region
Bombardi, C. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.006 · Cited by 54
Witteveen, J. S., Middelman, A., van Hulten, J. A., Martens, G. J. M., Homberg, J. R., & Kolk, S. M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00143 · Cited by 53
“The prefrontal pyramidal neurons express 5-HT1A, 5-HT2A and 5-HT6 receptors (Celada et al., 2001; Martin-Ruiz et al., 2001; Santana et al., 2004; Riccio et al., 2009) and by changing the level of extracellular 5-HT, the conveyed signals differ and can result in an altered cell identity.”
BackgroundStructure–Activity Relationships of Phenylalkylamines as Agonist Ligands for 5‐HT2A Receptors
Blaazer, A. R., Smid, P., & Kruse, C. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200800133 · Cited by 53
Ju, A., Fernandez-Arroyo, B., Wu, Y., Jacky, D., & Beyeler, A. (2020) · Molecular Brain · doi:10.1186/s13041-020-00605-5 · Cited by 47
Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei
Vázquez-Borsetti, P., Celada, P., Cortés, R., & Artigas, F. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000349 · Cited by 46
“…therapeutic action of antidepressant and antipsychotic drugs, which target transporters or receptors expressed by DA, 5-HT and PFC neurons (Arnt & Skarsfeldt, 1998; Artigas et al. 1996; Bymaster et al. 1996; Cortés et al. 1988; Mengod et al. 1989; Santana et al. 2004, 2009 ; Weiner et al. 1991).”
BackgroundAlmada, R. C., Coimbra, N. C., & Brandão, M. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.001 · Cited by 52
Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.049 · Cited by 53
“The effects of 5-MeO-DMT were more marked in V1 and mPFC than in MD thalamus, consistent with the high density of 5-HT1A-R and 5-HT2A-R in these cortical areas and their absence in thalamic nuclei (Pompeiano et al., 1992, 1994; Santana et al., 2004).”
BackgroundResultBurt, J. B., Preller, K. H., Demirtas, M., Ji, J. L., Krystal, J. H., Vollenweider, F. X., Anticevic, A., & Murray, J. D. (2021) · eLife · doi:10.7554/elife.69320 · Cited by 53
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
Thomas, C. W., Blanco‐Duque, C., Bréant, B. J. B., Goodwin, G. M., Sharp, T., Bannerman, D. M., & Vyazovskiy, V. V. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01846-9 · Cited by 52
Lladó-Pelfort, L., Assié, M., Newman‐Tancredi, A., Artigas, F., & Celada, P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2569-9 · Cited by 52
“%) of GABA interneurons expresses 5-HT1A receptors in mPFC, compared with 50–60% on pyramidal neurons (Santana et al. 2004).”
Haleem, D. J. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000123 · Cited by 51
“Low doses of ziprasidone, clozapine, and olanzapine increased dopamine release to approximately the same extent in the PFC as in the striatum, but higher doses resulted in an increasingly preferential effect on cortical dopamine release (Rollema et al., 2000).”
BackgroundInfluentialPattern of distribution of serotonergic fibers to the orbitomedial and insular cortex in the rat
Linley, S. B., Hoover, W. B., & Vertes, R. P. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.12.006 · Cited by 51
“of PCs, while 5-HT2A receptors are highly expressed on the apical dendrites of PCs; and finally (4) 5-HT1A and 5-HT2A receptorcontaining interneurons are primarily localized to deep layers (5/6) of the PFC and 5-HT3A containing INs to superficial layers of the PFC (Santana et al., 2004; Puig et al., 2010; Puig and Gul…”
Leriche, M., Méndez, M., Zimmer, L., & Bérod, A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.069 · Cited by 51
5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats
Solati, J., Salari, A., & Bakhtiari, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.058 · Cited by 50
Neurochemistry and Molecular Neurobiology of Aggressive Behavior
Miczek, K. A., Faccidomo, S., Fish, E. W., & DeBold, J. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-30405-2_7 · Cited by 50
Golden, C. T., & Chadderton, P. T. (2022) · Scientific Reports · doi:10.1038/s41598-022-16325-w · Cited by 49
Díaz-Mataix, L., Artigas, F., & Celada, P. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.003 · Cited by 49
“, 2000) and a subsequent drop of the 5-HT tone on prefrontal receptors controlling pyramidal activity (e.g. 5-HT2A and 5-HT3 receptors located on GABAergic interneurons; Tanaka and North, 1993; Zhou and Hablitz, 1999; Puig et al., 2004; Santana et al., 2004).”
BackgroundMa, L., Steinberg, J. L., Cunningham, K. A., Lane, S. D., Bjork, J. M., Neelakantan, H., Price, A. E., Narayana, P. A., Kosten, T. R., Bechara, A., et al. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.03.015 · Cited by 48
“…to pyramidal and GABAergic neurons within the frontal and cingulate cortex (CorneaHebert et al., 1999; Liu et al., 2007; Pompeiano et al., 1994; Santana et al., 2004), dopaminergic and GABAergic neurons of the caudate–putamen (Eberle-Wang et al., 1997; Lopez-Gimenez et al., 1997), and…”
BackgroundRGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer
Ahlers‐Dannen, K. E., Chakravarti, B., & Fisher, R. A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9899-9 · Cited by 48
Raju, C. S., Spatazza, J., Stanco, A., Larimer, P., Sorrells, S. F., Kelley, K. W., Nicholas, C. R., Paredes, M. F., Lui, J. H., Hasenstaub, A. R., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhx101 · Cited by 44
“Modern estimates indicate that GABAergic neurons comprise ~15% of all neocortical neurons in rats and mice and >20% in monkeys and humans (Lin et al. 1986; Fitzpatrick et al. 1987; Hendry et al. 1987; Meinecke and Peters 1987; Beaulieu et al. 1992, 1994; Ren et al. 1992; Beaulieu 1993; Hornung and De Tribolet 1994; Jo…”
BackgroundKirkcaldie, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10004-4 · Cited by 49
Huot, P., Fox, S. H., Newman‐Tancredi, A., & Brotchie, J. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184093 · Cited by 47
How Does the Brain Implement Adaptive Decision Making to Eat?
Compan, V., Walsh, B. T., Kaye, W. H., & Geliebter, A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2602-15.2015 · Cited by 47
“In the mPFC, the 5-HTR1A is localized, in the mPFC, in glutamatergic pyramidal efferent, local GABA-expressing interneurons (Czyrak et al., 2003; Amargós-Bosch et al., 2004; Santana et al., 2004) and on 5-HT terminals and, in the DR, on DR 5-HT neurons (Miquel et al.”
BackgroundSerotonin/dopamine interaction: Electrophysiological and neurochemical evidence
Deurwaerdère, P. D., Chagraoui, A., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.001 · Cited by 46
Herian, M., Wojtas, A., Kamińska, K., Świt, P., Wach, A., & Gołembiowska, K. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00033-x · Cited by 46
Kargieman, L., Riga, M. S., Artigas, F., & Celada, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.249 · Cited by 45
“5-HT1A receptor (5-HT1AR) and 5-HT2AR are abundantly expressed in rodent PFC (Pompeiano et al, 1992, 1994; Santana et al, 2004), where they are mostly co-expressed (Amargos-Bosch et al, 2004).”
BackgroundStephens, E. K., Avesar, D., & Gulledge, A. T. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00097 · Cited by 33
“While many cortical pyramidal neurons express both 1A and 2A receptors (Ashby et al., 1994; Amargós-Bosch et al., 2004; Béïque et al., 2004; Santana et al., 2004; Wȩdzony et al., 2008; Moreau et al., 2010), most display purely inhibitory or excitatory responses to 5-HT (Davies et al., 1987;…”
BackgroundResultInfluentialThe Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics
Mengod, G., Vilaró, M. T., Cortés, R., López‐Giménez, J. F., Raurich, A., & Palacios, J. M. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5 · Cited by 44
Devroye, C., Cathala, A., Piazza, P. V., & Spampinato, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.014 · Cited by 43
Law, A. J., Pei, Q., Feldon, J., Pryce, C. R., & Harrison, P. J. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009723 · Cited by 43
“At a cellular level, cortical 5-HT1ARs are mainly expressed by pyramidal neurons (Burnet et al., 1995; Palchaudhuri and Flügge, 2005; Santana et al., 2004) and most studies agree they are localised to the axon initial segment, with much lower levels elsewhere, e.g. in dendrites (Cruz et al., 2004;…”
BackgroundHuo, F.-Q., Chen, T., Lv, B.-C., Wang, J., Zhang, T., Qu, C. L., Li, Y.-Q., & Tang, J. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn169 · Cited by 43
The Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder
Maia, T. V., & Cano-Colino, M. (2015) · Clinical Psychological Science · doi:10.1177/2167702614566809 · Cited by 42
“The 5-HT1A and 5-HT2A receptors are present in not only cortical pyramidal neurons but also cortical γ-aminobutyric acid–producing (GABAergic) interneurons (Jakab & Goldman-Rakic, 2000; Puig, Watakabe, Ushimaru, Yamamori, & Kawaguchi, 2010; Santana et al., 2004; Weber & Andrade, 2010; Willins, Deutch, & Roth, 1997), w…”
BackgroundSzlachta, M., Kuśmider, M., Pabian, P., Solich, J., Kolasa, M., Żurawek, D., Dziedzicka‐Wasylewska, M., & Faron‐Górecka, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00040 · Cited by 42
“Both 5-HT1AR and 5-HT2AR are abundantly expressed in rodent PFC (Pompeiano et al., 1992, 1994; Santana et al., 2004), where they are mostly co-expressed (Amargós-Bosch et al., 2004).”
BackgroundRobbins, T. W., & Crockett, M. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70093-x · Cited by 42
Stockmeier, C. A., Howley, E., Shi, X., Sobanska, A., Clarke, G., Friedman, L., & Rajkowska, G. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.01.001 · Cited by 40
“The neurons immunostained with lower intensity may correspond to the GABA interneurons in rat cerebral cortex that express mRNA or immunoreactivity for the serotonin-1A receptor (Aznar et al., 2003; Santana et al., 2004).”
BackgroundAbdala, A. P., Bissonnette, J. M., & Newman‐Tancredi, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00205 · Cited by 42
“In fact, the high prevalence of OSAs is relevant for the treatment of respiratory disturbances in Rett syndrome since they have potential to generate a reciprocal feedback loop with central apneas resulting in respiratory irregularities.”
BackgroundIshii, H., Ohara, S., Tobler, P. N., Tsutsui, K., & Iijima, T. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.11.009 · Cited by 41
Riga, M. S., Bortolozzi, A. A., Campa, L., Artigas, F., & Celada, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.016 · Cited by 41
“These effects are due to the stimulation of 5-HT1A-R and 5- HT2A-R in pyramidal neurons (Santana et al, 2004) projecting to the DR (Gabbott et al, 2005; VazquezBorsetti et al, 2009).”
Yin, L., Rasch, M. J., He, Q., Wu, S., Dou, F., & Shu, Y. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv245 · Cited by 40
“Since both receptors co-expressed in the majority of PCs in PFC (Feng et al. 2001; Artigas et al. 2004; Santana et al. 2004), the sign of modulation (inhibition or facilitation) depends on the ratio of 5-HT1A to 5-HT2 expression levels.”
BackgroundInfluentialFunctional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders
Mitroshina, Е. V., Marasanova, E. A., & Vedunova, M. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216416 · Cited by 40
“It is widely distributed throughout the brain, with particularly high densities found in limbic areas, the hippocampus, septal and cortical regions, as well as in the dorsal and median raphe nuclei of the midbrain [66].”
BackgroundAnxiolytic effects of prelimbic 5-HT1A receptor activation in the hemiparkinsonian rat
Hui, Y. P., Wang, T., Han, L. N., Li, L. B., Sun, Y., Liu, J., Qiao, H. F., & Zhang, Q. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.053 · Cited by 40
Bailer, U. F., Bloss, C. S., Frank, G. K., Price, J. C., Meltzer, C. C., Mathis, C. A., Geyer, M. A., Wagner, A., Becker, C. R., Schork, N. J., et al. (2011) · International Journal of Eating Disorders · doi:10.1002/eat.20843 · Cited by 39
Todorović, N., Mićić, B., Schwirtlich, M., Stevanović, M., & Filipović, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.008 · Cited by 35
Ripoll, N., Hascoët, M., & Bourin, M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.013 · Cited by 40
Neural correlates and determinants of approach–avoidance conflict in the prelimbic prefrontal cortex
Fernández-León, J. A., Engelke, D. S., Aquino-Miranda, G., Goodson, A., Rasheed, M. N., & Monte, F. H. D. (2021) · eLife · doi:10.7554/elife.74950 · Cited by 39
“In contrast, inhibitory GABAergic interneurons comprise 15–25% of the local neurons ( Santana et al., 2004 ; Gabbott et al., 2005 ).”
Calcagno, E., Carli, M., Baviera, M., & Invernizzi, R. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05789.x · Cited by 35
“…mPFC (Aoki et al. 1994; Pompeiano et al. 1994; Abramowski et al. 1995; Kia et al. 1996b; Conti et al. 1997; Willins et al. 1997; Jakab and Goldman-Rakic 1998; Cornea-Hebert et al. 1999; Clemett et al. 2000; Lopez-Gimenez et al. 2001; MartinRuiz et al. 2001; Miner et al. 2003; Santana et al. 2004).”
Background
Metadata
- Authors
- Santana, N.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Santana, N.
- ORCID
- Santana, N.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-27
- Volume
- 14
- Issue
- 10
- Pages
- 1100-1109
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2156868152
- Cited by
- 486
- References
- 80
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 29 · 2023: 19 · 2022: 11 · 2021: 34 · 2020: 20 · 2019: 14 · 2018: 21 · 2017: 23 · 2016: 23 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 19
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- 5-HT1A receptor, 5-HT2A receptor, prefrontal cortex, pyramidal neurons, GABAergic interneurons, glutamatergic neurons, receptor colocalization, atypical antipsychotics, prelimbic cortex, cortical layers
- MeSH terms
- Animals, gamma-Aminobutyric Acid, Gene Expression Regulation, Male, Neurons, Rats, Wistar, Prefrontal Cortex, Pyramidal Cells, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.